Alzamend Neuro | 8-K: Current report
May 1 04:34
Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III
Apr 24 08:06
Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III
Apr 4 05:05
Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III
Apr 2 04:56
Alzamend Neuro | 8-K: Current report
Mar 30 04:34
Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III
Mar 29 04:36
Alzamend Neuro | 10-Q: Quarterly report
Mar 26 05:31
Alzamend Neuro | DEF 14A: Definitive information statements
Mar 26 04:50
Alzamend Neuro | 8-K: Current report
Mar 23 04:34
Alzamend Neuro | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Mar 19 04:31
Alzamend Neuro | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 14 04:38
Alzamend Neuro | 8-K: Current report
Mar 8 05:38
Alzamend Neuro | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MILTON C. AULT, III(40.3%),AULT ALLIANCE, INC.(25.4%), etc.
Feb 3 05:42
Alzamend Neuro | 8-K: Current report
Feb 3 05:31
Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III
Feb 3 05:31
Alzamend Neuro | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MILTON C. AULT, III(29.4%),AULT LIFE SCIENCES, INC.(15.1%), etc.
Jan 26 06:26
Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III
Jan 26 06:21
Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III
Jan 9 13:00
Alzamend Neuro | 8-K: Current report
Jan 5 13:00
Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-10% Owner AULT MILTON C III
Dec 27, 2023 13:00
No Data
No Data